Impact of Constipation on Health Outcomes in Medically Hospitalized Patients: A Prospective Study on Laxative Use and Health Care Outcomes

• Published in: Medicina (Kaunas, Lithuania) Lithuania), 2024-09, Vol.60 (10), p.1599
• Main Authors: Al Alawi, Abdullah M, Al Nou'mani, Jawahar, Al Abri, Nahid, Al Sabbri, Maryam, Al-Maqbali, Juhaina Salim
• Format: Article
• Language: English
• Subjects: Adult; Aged; Aged, 80 and over; Anemia; Cohort analysis; Cohort Studies; Complications and side effects; Constipation; Constipation - drug therapy; Diabetes; Female; Frailty; Heart failure; Hospital costs; Hospital patients; Hospitalization; Hospitalization - statistics & numerical data; Humans; Hypothyroidism; in-hospital; inpatient; Intensive care; Laxatives; Laxatives - therapeutic use; Length of stay; Length of Stay - statistics & numerical data; Male; Middle Aged; Mortality; Outcome Assessment, Health Care - statistics & numerical data; Patient outcomes; Prognosis; Prospective Studies; Quality of Life; Regression analysis; Statistical analysis
• ISSN: 1648-9144; 1010-660X; 1648-9144
• DOI: 10.3390/medicina60101599

Constipation affects health-related quality of life and increases hospital visits. We conducted this prospective cohort study to assess laxative use, health outcomes of constipation in medically hospitalized patients, and related health outcomes. A prospective single-center study included all adult patients admitted under the General Internal Medicine Unit from 1 February 2022, to 31 August 2022. Constipation was defined using the Constipation Assessment Scale (CAS). Patients were assessed for 28 days during their hospital stay and up to 90 days post-discharge. Among the included patients, 62.45% experienced constipation, which was associated with poor health outcomes including delirium ( = 0.048), intensive care admission ( < 0.01), cardiopulmonary arrest ( < 0.01), inpatient mortality ( < 0.01), longer hospital stay ( < 0.01), 90-day mortality ( < 0.01), and 90-day hospital readmission ( < 0.01). Laxative treatment was administered to only 33.93% of patients with constipation and was more commonly used among older patients ( < 0.01), those with high CAS scores ( < 0.01), longer hospital stays ( < 0.01), and critically ill patients (intensive care admission) ( = 0.01), as well as those who had cardiopulmonary arrest ( < 0.01) and high inpatient mortality ( < 0.01). This study identified several associations between constipation and poor health outcomes and highlighted the underutilization of laxatives in treating constipation. It is vital to interpret our results with caution. Therefore, we believe that a randomized controlled trial will help enhance our understanding of the interaction between constipation, laxative use, and poor health outcomes.